No detectable untoward consequences on nonneoplastic cells, in vitro. Although it blocks competitively the binding of dihydrotestosterone (DHT) to its protein receptor, it has no major outcomes on both estrogen or progesterone receptors. CPC 10997 was observed being more effective against carcinomas of the breast, the kidney, the ovary and https://alcuinr000kwg4.thekatyblog.com/profile